Last reviewed · How we verify

Continuous spinal anesthesia

Mahmoud Rashad Ahmed · FDA-approved active Small molecule

Continuous spinal anesthesia delivers local anesthetic agents directly into the cerebrospinal fluid via an indwelling catheter to produce prolonged regional anesthesia of the lower body and lower extremities.

Continuous spinal anesthesia delivers local anesthetic agents directly into the cerebrospinal fluid via an indwelling catheter to produce prolonged regional anesthesia of the lower body and lower extremities. Used for Surgical anesthesia for lower abdominal, pelvic, and lower extremity procedures, Postoperative pain management, Labor analgesia.

At a glance

Generic nameContinuous spinal anesthesia
SponsorMahmoud Rashad Ahmed
Drug classLocal anesthetic (regional anesthesia technique)
ModalitySmall molecule
Therapeutic areaAnesthesiology
PhaseFDA-approved

Mechanism of action

This technique involves placement of a catheter into the subarachnoid space, allowing repeated or continuous infusion of local anesthetics (such as lidocaine, bupivacaine, or ropivacaine) to maintain anesthesia throughout a surgical procedure or postoperative period. The local anesthetic blocks nerve conduction in spinal nerve roots, producing sensory and motor blockade in the distribution of the spinal nerves. This approach extends the duration of anesthesia beyond single-injection spinal anesthesia and allows for dose titration.

Approved indications

Common side effects

Key clinical trials

Primary sources

Every claim on this page is sourced from regulatory or scientific primary sources. See our editorial policy for full methodology.

SourceUsed for
ClinicalTrials.govTrial enrolment, design, endpoints, results